Yasushi Sato

2PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Nov 09, 2018
A dose-escalation study of docetaxel, oxaliplatin, and S-1 (DOS) as a first-line therapy for patients with unresectable metastatic gastric cancer.

Yasushi Sato, Tamotsu Sagawa, Hiroyuki Ohnuma

|Oct 18, 2017
A triplet combination with capecitabine/oxaliplatin/irinotecan (XELOXIRI) plus cetuximab as first-line therapy for patients with metastatic colorectal cancer: a dose escalation study.

Yasushi Sato, Masahiro Hirakawa, Hiroyuki Ohnuma

Pageof 1

Frequent Collaborators